Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma
分子肿瘤委员会：在肺腺癌病例中，通过鉴定和功能验证新的ALK耐药突变，进行分子水平调整治疗
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae143
Arndt, Annette; Neumann, Christian; Riecke, Armin; Bauer, Arthur; Müller, Matthias; Wölfle-Guter, Manuela; Grunert, Michael; Busch, Hauke; Künstner, Axel; von Bubnoff, Nikolas; Fliedner, Stephanie; Greinert, Dina; Osius, Jasmin; Nagarathinam, Kumar; Steinestel, Konrad; Gorantla, Sivahari Prasad; Gebauer, Niklas; Witte, Hanno M
